The Nation's Leading Lung Cancer Organizations Join Forces to Launch "GO2 Foundation for Lung Cancer"

(San Carlos, CA and Washington, DC) – Two of the most effective and influential nonprofit organizations serving the lung cancer community, the Bonnie J. Addario Lung Cancer Foundation (ALCF) and Lung Cancer Alliance (LCA) today proudly announced they are joining forces as the GO2 Foundation for Lung Cancer. Together they become the "go-to" local and global force serving and advocating for the needs of the millions of people who are vulnerable, at risk or diagnosed, and all others impacted by or impacting the disease.

The Registry Advances Cancer Research with 2 New Abstract Publications

Thank you for your participation in the Bonnie J. Addario Lung Cancer Registry! We are happy to announce two more abstracts have been accepted for presentation. Read below about the scientific meetings where your anonymous patient data will be presented:

Happy Holidays and New Year from the Registry

As we come to an end of 2018 we would like to reflect on the advances the Registry has made, and express our gratitude for your invaluable contributions to lung cancer research.

Lung Cancer Registry - Lung Cancer Patient Survey Analysis September 2018 (June 2018 Data)

This September 2018 analysis provides patient insights from the patient reported data collected through the “Lung Cancer Patient Survey” in the Lung Cancer Registry from November 2016 - June of 2018.

Examination of Genetic Alterations in Young Lung Cancer Patients From the Lung Cancer Registry

The Power of One Leads to Progress for Many - Interview Sandra Shaw Director of the Lung Cancer Registry

Reprinted with permission from Patient Resource LLC. Copyright 2019 Patient Resource LLC

A Real-World Example: ALCF Immunotherapy Survey

The current ALCF immunotherapy survey is an example of how the registry can be used in research with patients in specific subpopulations to help fill in known information gaps. The survey is a research study exploring the side effects patients experience when receiving treatment with immune checkpoint inhibitors, which is a form of immunotherapy.